Avid Bioservices Inc (CDMO)

[BioChica]

AF does not believe small cap biomeds can develop effective drugs with out partnership with "Big Pharma", most small cap's fail. Since the Peregrine Management has failed to gain FDA over many years, he has a point. But he fails to mention we have an inhouse expert Robert Garnick now to guide Peregrine drug development.

Quoted from an artical:

Navigating the regulatory waters alone can be daunting for a small company. But Peregrine has a seasoned skipper for the important job: Robert Garnick, a 24-year veteran of Genentech. In his two decades at the biotech company (now part of Roche), Garnick oversaw 17 product approvals, including for top-selling drugs Rituxan, Herceptin, Avastin, and Lucentis.